# Evaluation of Safety and Tolerability of Fetal Mesencephalic Dopamine Neuronal Precursor Cells for Parkinson's Disease

> **NCT01860794** · PHASE1,PHASE2 · UNKNOWN · sponsor: **Bundang CHA Hospital** · enrollment: 15 (estimated)

## Conditions studied

- Idiopathic Parkinson Disease
- Primary Parkinsonism

## Interventions

- **DRUG:** Mesencephalic Neuronal Precursor Cells

## Key facts

- **NCT ID:** NCT01860794
- **Lead sponsor:** Bundang CHA Hospital
- **Sponsor class:** OTHER
- **Phase:** PHASE1,PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2013-05
- **Primary completion:** 2022-04
- **Final completion:** 2022-04
- **Target enrollment:** 15 (ESTIMATED)
- **Last updated:** 2020-07-10


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01860794

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01860794, "Evaluation of Safety and Tolerability of Fetal Mesencephalic Dopamine Neuronal Precursor Cells for Parkinson's Disease". Retrieved via AI Analytics 2026-06-15 from https://api.ai-analytics.org/clinical/NCT01860794. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*